These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21498718)

  • 1. Fascin and CK4 as biomarkers for esophageal squamous cell carcinoma.
    Takikita M; Hu N; Shou JZ; Giffen C; Wang QH; Wang C; Hewitt SM; Taylor PR
    Anticancer Res; 2011 Mar; 31(3):945-52. PubMed ID: 21498718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
    Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue microarray analysis reveals a tight correlation between protein expression pattern and progression of esophageal squamous cell carcinoma.
    Xue LY; Hu N; Song YM; Zou SM; Shou JZ; Qian LX; Ren LQ; Lin DM; Tong T; He ZG; Zhan QM; Taylor PR; Lu N
    BMC Cancer; 2006 Dec; 6():296. PubMed ID: 17187659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fascin is a potential biomarker for early-stage oesophageal squamous cell carcinoma.
    Zhang H; Xu L; Xiao D; Xie J; Zeng H; Cai W; Niu Y; Yang Z; Shen Z; Li E
    J Clin Pathol; 2006 Sep; 59(9):958-64. PubMed ID: 16524962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of fascin in human esophageal squamous cell carcinoma and its clinical significance].
    Qin YR; Tang H; Qiao JJ; Li FF; Ai JY
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(7):1216-9. PubMed ID: 21764699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24 and CK4 are upregulated by SIM2, and are predictive biomarkers for chemoradiotherapy and surgery in esophageal cancer.
    Takashima K; Fujii S; Komatsuzaki R; Komatsu M; Takahashi M; Kojima T; Daiko H; Minashi K; Chiwaki F; Muto M; Sasaki H; Yano T
    Int J Oncol; 2020 Mar; 56(3):835-847. PubMed ID: 32124945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
    Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines.
    Ortiz CM; Ito T; Hashimoto Y; Nagayama S; Iwai A; Tsunoda S; Sato F; Martorell M; Garcia JA; Perez A; Shimada Y
    Diagn Pathol; 2010 Jun; 5():41. PubMed ID: 20565981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.
    Xie JJ; Xu LY; Wu JY; Shen ZY; Zhao Q; Du ZP; Lv Z; Gu W; Pan F; Xu XE; Xie D; Li EM
    Am J Pathol; 2010 Feb; 176(2):939-51. PubMed ID: 20056838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of fascin decreases the risk of poor survival in patients with esophageal squamous cell carcinoma.
    Zhao Q; Shen JH; Shen ZY; Wu ZY; Xu XE; Xie JJ; Wu JY; Huang Q; Lu XF; Li EM; Xu LY
    J Histochem Cytochem; 2010 Nov; 58(11):979-88. PubMed ID: 20713986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Analyses of Gene Expression following Fascin Knockdown in Esophageal Squamous Cell Carcinoma Cells.
    Du ZP; Wu BL; Xie JJ; Lin XH; Qiu XY; Zhan XF; Wang SH; Shen JH; Li EM; Xu LY
    Asian Pac J Cancer Prev; 2015; 16(13):5445-51. PubMed ID: 26225692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of fascin in the proliferation and invasiveness of esophageal carcinoma cells.
    Xie JJ; Xu LY; Zhang HH; Cai WJ; Mai RQ; Xie YM; Yang ZM; Niu YD; Shen ZY; Li EM
    Biochem Biophys Res Commun; 2005 Nov; 337(1):355-62. PubMed ID: 16185662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular prognostic model predicts esophageal squamous cell carcinoma prognosis.
    Cao HH; Zheng CP; Wang SH; Wu JY; Shen JH; Xu XE; Fu JH; Wu ZY; Li EM; Xu LY
    PLoS One; 2014; 9(8):e106007. PubMed ID: 25153136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive bioinformation analysis of the mRNA profile of fascin knockdown in esophageal squamous cell carcinoma.
    Wu BL; Luo LW; Li CQ; Xie JJ; Du ZP; Wu JY; Zhang PX; Xu LY; Li EM
    Asian Pac J Cancer Prev; 2013; 14(12):7221-7. PubMed ID: 24460279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas.
    Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP
    Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY
    Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.